Extraction method of Kefir-sourced lactobacillus extracellular vesicles and application of Kefir-sourced lactobacillus extracellular vesicles in improvement of potential probiotics of lactobacillus
By optimizing the extraction method of lactic acid bacteria EVs, the microbial residue, membrane structure damage and biological activity influence during EVs extraction in the prior art was solved, and the probiotic properties of lactic acid bacteria were successfully improved, especially in the application of fermented milk, which significantly improved the application of fermented milk. Adhesion and antibacterial properties.
Patent Information
- Application Number
- CN202411513966.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-29
- Publication Date
- 2024-11-26
AI Technical Summary
In the prior art, the microbial EVs extraction process has insufficient filtration, resulting in microbial residues, ultracentrifugation leads to membrane structure damage and functional protein denaturation, and density gradient centrifugation residues affect biological activity, and it is not effective to extract and apply lactic acid bacteria EVs from fermented foods.
The extraction methods of L. kefiri 29 and E. faecium 14 EVs were optimized, and cell debris was removed by low-speed centrifugation, impurities were removed by multi-layer filter membrane filtration, and ultra-high-speed centrifugation ensured the integrity of EVs, obtain high-purity and biologically active EVs, and then the It is diluted and added to lactic acid bacteria to enhance probiotics.
Improve the adhesion, acid resistance, bile salt resistance and antibacterial properties of lactic acid bacteria, ensure the safety and functional integrity of EVs, significantly enhance the potential probiotic properties of lactic acid bacteria, especially in the application of fermented milk. .
Smart Images

Figure CN119020245A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of lactic acid bacteria, and in particular to a method for extracting extracellular vesicles of kefir-derived lactic acid bacteria and application of the method in improving the potential probiotic properties of lactic acid bacteria. Background Art
[0002] Kefir is a low-alcohol, acidic, frothy milk drink made by fermenting kefir grains with fresh milk. Kefir has a flavor different from other fermented milk drinks, it is called "champagne yogurt" and has rich nutritional value. Its flavor characteristics and health value are determined by the naturally formed complex microbial environment. During the microbial interaction and self-metabolism, they produce nutrients such as polysaccharides, which gradually accumulate into the extracellular matrix (ECM) along with other substances, and then form a biofilm that encapsulates the structured microbial cell group. This cell group can quickly adapt to the extracellular microenvironment. The microbial composition of kefir grains from different sources varies, but according to the type of microorganisms present, they are mainly divided into three types: lactic acid bacteria, yeasts, and acetic acid bacteria. The metabolites produced by lactic acid bacteria (glucose, galactose, etc.) can be used as energy sources for yeasts and acetic acid bacteria, while the growth factors produced by yeasts (vitamins, amino acids, etc.) are essential for the growth and reproduction of lactic acid bacteria and acetic acid bacteria. Substances such as CO2, ethanol, and lactic acid produced in this process also inhibit the production of spoilage microorganisms. Therefore, there is a natural and stable functional bacterial system in kefir.
[0003] In the complex microbial system of kefir, lactic acid bacteria such as Lactobacillus helveticus, Lactococcus lactis, Leuconostoc entericus, Lactobacillus kefir, and Lentilactobacillus sunkii dominate (80%). Compared with other microorganisms, related studies have explored the characteristics of lactic acid bacteria from different kefir sources more. This is because lactic acid bacteria are more representative and have a higher proportion in kefir. Moreover, kefir-derived lactic acid bacteria have a relatively large protective effect on the human body and have multiple benefits; therefore, they are more valuable for development. It is worth noting that the probiotic properties of kefir-derived lactic acid bacteria are attributed to the bioactive substances they produce during kefir fermentation and metabolism. Exopolysaccharides (EPS) produced by kefir-derived lactic acid bacteria have strong probiotic functions and physical properties (stability, emulsification, gelation, etc.), so they have broad application prospects. Studies have confirmed that EPS produced by lactic acid bacteria is one of the important components of extracellular polymer precursors for biofilm construction. This is particularly evident in the fermentation system of kefir. Therefore, exploring the EPS and biofilm produced by microorganisms, especially lactic acid bacteria, in the kefir system will help study the mechanism of action of kefir particles.
[0004] Extracellular vesicles (EVs) are spherical nanoparticles composed of a transmembrane protein lipid bilayer. They are released by cells and carry the biologically active components of the parent body. As a cell-to-cell communication tool with multiple biological functions, EVs are often used as an important carrier for transporting bioactive components and have great potential and application value in the fields of biopharmaceuticals, stem cell regenerative medicine, and tumor diagnosis. The main source of EV samples currently available is animal biological fluids, but there are no reports on obtaining EVs from fermented foods, nor on using EVs to improve the potential probiotics of lactic acid bacteria. Summary of the invention
[0005] The first purpose of the present invention is to overcome the shortcomings of the prior art and provide a method for extracting extracellular vesicles of kefir-derived lactic acid bacteria.
[0006] The first object of the present invention is achieved by the following technical solution: a method for extracting extracellular vesicles of kefir-derived lactic acid bacteria, characterized by comprising the following steps: 1) The fermentation culture of kefir-derived lactic acid bacteria was centrifuged at 4°C and 10,000 × g for 30 min to remove cell debris and collect the supernatant; 2) Use a 0.45 μm filter membrane to filter out floating impurities in the supernatant; 3) The supernatant was concentrated 25 times by ultrafiltration through a 100 KD ultrafiltration tube, and the concentrate was transferred to a centrifuge tube; 4) Blow 100 uL PBS buffer into the 100 KD ultrafiltration tube described in step 3) and collect the leaked liquid; 5) The concentrated solution in step 3) is mixed with the leaked solution in step 4) to obtain a final concentrated solution, and the final concentrated solution is filtered using a 0.22 um filter membrane to obtain a crude EVs extract; 6) The crude EVs extract was purified by ultra-high-speed centrifugation at 4°C and 120,000×g for 90 min. The EVs precipitate was resuspended in 100 uL PBS buffer precooled to 4°C and stored at -80°C.
[0007] By comparing the existing extraction methods of microbial EVs, we found that there are some common problems in the extraction process. For example, the failure to filter small molecules will lead to microbial residues and reduce the purity of EVs; in the ultracentrifugation process, too fast a speed or too long a time will damage the membrane structure of EVs, resulting in leakage of contents or denaturation of functional proteins; and density gradient centrifugation often has gradient liquid residues, which will affect the biological activity of EVs if they are not completely removed in subsequent steps. Based on the above effects, the present invention optimizes the EVs extraction method of L. kefiri 29 and E. faecium 14, and the targeted optimization contents are as follows: 1) Since the strain can produce a large amount of EPS, the bacterial solution forms light and loose bacterial clumps or biofilms, so it is impossible to ensure that the bacteria sink completely at a low speed. Therefore, the centrifugal speed in step 1) is selected to be 10000×g to ensure that the bacteria are completely precipitated, avoid floating, and obtain a clean supernatant for the extraction of EVs. 2) 0.45μm and 0.22μm filters were used before and after ultrafiltration. On the one hand, it can gradually remove impurities of different sizes in the supernatant and reduce the risk of microbial contamination. On the other hand, it can protect the ultrafiltration membrane to a certain extent, ensuring that the ultrafiltration process will not be blocked and affect the subsequent extraction of EVs. 3) In step 6, the ultracentrifugation speed is 120,000×g for 90min. This optimized combination can ensure the complete separation of EVs while avoiding the destruction of the EV structure, ensuring the integrity of its contents and improving the recovery rate of EVs.
[0008] The second purpose of the present invention is to overcome the shortcomings of the prior art and provide a method for extracting extracellular vesicles of kefir-derived lactic acid bacteria and the application of the extracted extracellular vesicles in improving the potential probiotic properties of lactic acid bacteria.
[0009] The second objective of the present invention is achieved through the following technical scheme: a method for extracting extracellular vesicles of kefir-derived lactic acid bacteria, and applying the extracted extracellular vesicles to improving the potential probiotics of lactic acid bacteria. The separated extracellular vesicles of kefir-derived lactic acid bacteria are diluted to a concentration of 1 μg / mL, exogenously added to the lactic acid bacteria strain at an inoculation amount of 10% v / v, mixed, and cultured at 37°C for 24 hours.
[0010] The probiotics are the adhesion, acid and bile resistance and antibacterial properties of lactic acid bacteria to which kefir-derived lactic acid bacteria extracellular vesicles are exogenously added. After exogenous addition of EVs, the adhesion, acid and bile resistance and antibacterial properties of lactic acid bacteria are significantly improved, while safety is guaranteed. Among them, the high adhesion feature is particularly prominent, and its application in fermented milk has significant advantages.
[0011] The beneficial effect of the present invention is that the present invention extracts kefir-derived lactic acid bacteria EVs, and by exogenously adding kefir-derived lactic acid bacteria EVs to lactic acid bacteria strains, the potential probiotic properties of lactic acid bacteria can be effectively improved. BRIEF DESCRIPTION OF THE DRAWINGS
[0012] Figure 1 yes L. kefiri 29 Transmission electron microscopy image of EVs of lactic acid bacteria; Figure 2 yes E. faecium 14 Transmission electron microscopy images of EVs of lactic acid bacteria; Figure 3 yes L. kefiri 29 Particle size / concentration distribution of EVs of lactic acid bacteria; Figure 4 yes E. faecium 14 Particle size / concentration distribution of EVs of lactic acid bacteria; Figure 5 is the graph of EVs protein content of the strains; Figure 6 This is the Venn diagram of kefir-derived lactic acid bacteria EVs protein; Figure 7 yes L. kefiri GO of proteins in EVs of lactic acid bacteria Figure 1 ; Figure 8 yes L. kefiri GO of proteins in EVs of lactic acid bacteria Figure 2 ; Fig. 9 yes L. kefiri GO of proteins in EVs of lactic acid bacteria Figure 3 ; Fig.10 yes E. faecium GO of proteins in EVs of lactic acid bacteria Figure 1 ; Fig.11 yes E. faecium GO of proteins in EVs of lactic acid bacteria Figure 2 ; Fig.12 yes E. faecium GO of proteins in EVs of lactic acid bacteria Figure 3 ; Fig.13 yes L. kefiri 29 Subcellular localization of EVs of lactic acid bacteria; Fig.14 yes E. faecium 14 Subcellular localization of EVs of lactic acid bacteria; Fig.15 yes L. kefiri 29 KEGG metabolic pathway diagram of EVs of lactic acid bacteria; Fig.16 yes E. faecium14 KEGG metabolic pathway diagram of EVs of lactic acid bacteria; Fig.17 It is the lactic acid bacteria adhesion column with exogenously added EVs Figure 1 ; Fig.18 It is the lactic acid bacteria adhesion column with exogenously added EVs Figure 2 ; Fig.19 It is a graph of hemolysis of lactic acid bacteria with exogenously added EVs. DETAILED DESCRIPTION
[0013] The present invention is described in detail below with reference to the accompanying drawings. 1 Materials and methods
[0014] 1.1 Determination of EPS production and biofilm formation ability of kefir-derived lactic acid bacteria The bacterial solution was inoculated into MRS medium (inoculation rate 3% v / v), and the bacterial amount was adjusted to OD600nm=1 before subsequent experiments.
[0015] The phenol-sulfuric acid method was used to determine the production of EPS. The bacterial solution was centrifuged at 3000×g for 10 min, and the supernatant was retained. Then 4 times of anhydrous ethanol was added, and the mixture was precipitated at 4°C for 12 h. After centrifugation at 7600×g for 10 min, the supernatant was discarded. Then 10 mL of distilled water was added to the residue, shaken well, and poured into a dialysis bag (3500 Da) and stored for 12 h. 500 μL of phenol solution was added to 500 μL of sample solution, followed by 2.5 mL of concentrated sulfuric acid. After standing for 10 min, the absorbance was measured at OD490 nm.
[0016] The crystal violet staining method was used to determine the biofilm-forming ability of lactic acid bacteria. The bacterial solution was added to a 96-well cell culture plate (200 μL / well) and cultured at 37°C for 24 h. The supernatant was discarded and the cell culture plate was washed with sterile PBS buffer to remove the floating bacteria that did not form a biofilm. Then, a 10% methanol solution was added to the plate to fix the cells for 15 min. After discarding the methanol, the cells were stained with a 0.1% crystal violet dye solution for 20 min, and the waste dye solution was washed three times with sterile PBS buffer. Subsequently, a 95% ethanol solution was added for 10 minutes to decolorize the cells. The absorbance was measured at OD560nm and OD620nm. The ability to form a specific biofilm is expressed by SBF.
[0017] SBF = (AB−CW) / G AB——OD560 of attached bacteria nm CW——culture medium OD560 nm G——Bacterial OD620 nm 1.2 Characterization of extracellular vesicles of kefir-derived lactic acid bacteria 1.2.1 Extraction of extracellular vesicles 1) The fermentation culture of kefir-derived lactic acid bacteria was centrifuged at 4°C and 10,000×g for 30 min to remove cell debris and collect the supernatant; 2) The floating impurities in the supernatant were filtered using a 0.45 μm filter membrane; 3) The supernatant was ultrafiltered and concentrated 25 times using a 100 KD ultrafiltration tube, and the concentrate was transferred to a centrifuge tube; 4) 100 uL PBS buffer was blown into the 100 KD ultrafiltration tube described in step 3) and the leaked liquid was collected; 5) The concentrate in step 3) was mixed with the leaked liquid in step 4) to obtain a final concentrate, and the final concentrate was filtered using a 0.22 μm filter membrane to obtain a crude EVs extract; 6) The crude EVs extract was subjected to ultracentrifugation at 4°C and 120,000×g for 90 min (Hitachi, Japan) to obtain purified EVs, and the EVs precipitate was resuspended with 100 uL PBS buffer precooled to 4°C and stored at -80°C.
[0018] 1.2.2 Structural characteristics of extracellular vesicles Transmission electron microscopy (TEM) was used to observe the morphology of EVs. 10 μL of EVs were placed on a copper mesh plate for 5-10 min, and the excess liquid was absorbed with filter paper. The cells were stained with 2% uranyl acetate (10 μL) and observed using a HT7700 transmission electron microscope (Hitachi, Japan).
[0019] The number and size of EVs were measured by nanoparticle tracking analysis (NTA) using ZetaView_Particle Metrix (Particle Metrix, PMX-120, Germany). The instrument was calibrated using 100 nm polystyrene beads (ThermoFisher Scientific, Fremont, USA) before use. The nanoparticle concentration (particles / mL) was determined using the NTA software. The measurements were performed using the batch processing method included in the NTA software.
[0020] 1.2.3 Protein content of extracellular vesicles The total protein concentration of EVs in lactic acid bacteria was determined using a modified BCA protein assay kit (Shanghai Bioengineering Technology Service Co., Ltd., China).
[0021] 1.3 Label-free quantitative proteomics technology 1.3.1 Sample preparation Lysis buffer was added to the sample to make the final concentration 1% SDC / 100 mM Tris-HCl (pH=8.5), ultrasonically disrupted, centrifuged at 12000×g for 5 min, and the supernatant was taken. The protein concentration of the supernatant was determined by BCA method. Take an equal amount of protein and use 1% SDC / 100 mM Tris-HCl (pH=8.5) solution to make up to the same volume. After adding TCEP and CAA, incubate at 60℃ for 30 min to complete reduction and alkylation. Add an equal volume of ddH20 to dilute the SDC concentration to less than 0.5%, add trypsin at a mass ratio of 1:50 between enzyme and protein, and incubate at 37℃ with shaking overnight for enzyme digestion. Add TFA to terminate the enzyme digestion reaction, centrifuge the sample at 12000×g, take the supernatant and desalt it with a homemade SDB desalting column, vacuum dry, and freeze at -20℃.
[0022] 1.3.2 Mass spectrometry Ion mobility (TIMS)-quadrupole-time of flight mass spectrometry was used. The UltiMate 3000 RSLCnano system (Thermo) was connected to the timsTOF Pro via a CaptiveSpray nano-ion source (Bruker). The peptide samples were injected into a C18 Trap column (75 um × 2 cm, 3 um particle size, 100A pore size, Thermo) through an autosampler and separated on a reversed-phase C18 analytical column (75 μm × 15 cm, 1.7 μm particle size, 100 A pore size, IonOpticks). The separation gradient was established with mobile phase A (0.1% formic acid) and mobile phase B (0.1% formic acid / 99.9% acetonitrile). PASEF mode was used, with a capillary voltage of 1500 V. The acquisition range of MS1 and MS2 spectra was set to 100-1700 m / z. Ion mobility 1 / K0: 0.75-1.4 Vs / cm 2 . Accumulation time, ramp time: 100 ms. Acquisition cycle time: 1.16 seconds. Target intensity: 10000. Quadrupole isolation window: 2.0 Da (m / z 700), 3.0 Da (m / z 800). Collision energy: from 1 / K0 = 1.6 Vs / cm 2 The 59eV is linearly reduced to 1 / K0=0.6Vs / cm 2 20 eV. Dynamic exclusion time: 0.4 min.
[0023] 1.3.3 Database search The raw mass spectrometry data were analyzed using MaxQuant (2.1.2.0) software, using the Andromeda database search algorithm, and the database used for the search was Uniprot. Enterococcus_faeciumProtein sequence database (24012320, 3055 protein entries), Uniprot Lactobacillus_kefiri Protein sequence database (24012320, 2359 protein entries). Label-free quantification was performed using the MaxLFQ algorithm with the “match-between-runs” function turned on. Search results were filtered using 1% FDR (protein and peptide level).
[0024] 1.4 Determination of the potential probiotic effects of lactic acid bacteria exogenously added with kefir-derived lactic acid bacteria EVs The isolated kefir-derived lactic acid bacteria EVs were diluted to a concentration of 1 μg / mL, exogenously added to the lactic acid bacteria strain at a 10% inoculum (v / v), mixed, and cultured at 37°C for 24 hours as the experimental group. The control group was lactic acid bacteria without EVs.
[0025] 1.4.1 Adhesion Self-aggregation: Centrifuge the cultured bacterial solution at 3000×g for 15 min and collect the lower layer. Wash the contents of the lower layer twice with PBS and resuspend in the same buffer to obtain an absorbance value of 0.9-1.0 at 600 nm (A0). Then, take 4 mL of the suspension, shake it for 10 seconds, and let it stand at room temperature. Subsequently, collect 0.1 mL of the supernatant at 1, 3, and 5 h, transfer it to a test tube containing 3.9 mL of PBS buffer, rotate it, and mix it. Measure the absorbance at 600 nm (At). Self-aggregation is calculated as follows: Self-aggregation (%) = (1−A t / A0)×100% Hydrophobicity: The cultured bacterial solution was centrifuged at 3000×g for 15 minutes, washed twice with PBS buffer and resuspended to make the absorbance of the cells at 600nm 0.9-1.0 (A0). Then, 1mL of xylene was added to 3mL of lactic acid bacteria suspension, mixed thoroughly, and allowed to stand at room temperature for 30 minutes to completely separate the organic phase and the aqueous phase. The absorbance value of the aqueous phase was measured at 600nm using PBS buffer A0 as a control. The hydrophobicity was calculated as follows: Hydrophobicity (%) = [(A0 − A t ) / A0]×100% 1.4.2 Tolerance of lactic acid bacteria to acid and bile salts The lactic acid bacteria with an inoculum amount of 3% (v / v) were inoculated into acidic MRS medium (pH = 3) and MRS medium containing bile salts (0.3% (w / v) bile salts), respectively, and incubated at 37°C for 3 h. Samples were collected and streaked after 0 h and 3 h, respectively, to determine the number of live lactic acid bacteria.
[0026] 1.4.3 Determination of antibacterial ability of lactic acid bacteria The agar diffusion method was used to determine the antibacterial ability of lactic acid bacteria. Lactic acid bacteria fermentation broth and cell-free supernatant were prepared (3000×g, 10 min). Nutrient agar was added to the culture dish and an Oxford cup was inserted. Laboratory-preserved pathogenic bacteria (from the Japan Bioresource Center) were Escherichia coli NBRC3301 and Salmonella typhimurium NBRC12529 from Tokyo Medical University Staphylococcus aureus ⅡD1617) was activated, nutrient agar medium was added, and the Oxford cup was removed from the Oxford cup after the medium was completely solidified. Subsequently, 100 μL of fermentation broth and supernatant were added to the hole (H1), respectively. Incubate at 37℃ for 48h, and 100 μL of 1 mg / mL polymyxin B was used as a positive control (H2). The inhibition diameter of each hole was measured. The relative inhibition rate (I) of the strain was calculated as follows: I = H1 / H2 × 100% 1.4.4 Safety determination of lactic acid bacteria Drug resistance: The antibiotic sensitivity pattern was determined by the Kirby-Bauer standard disk diffusion method. Nine different antibiotic sensitive papers, including cefazolin, penicillin, ampicillin, erythromycin, gentamicin, amikacin, chloramphenicol, ciprofloxacin and norfloxacin, were selected to detect the resistance of lactic acid bacteria to these antibiotics. First, the fresh lactic acid bacteria fermentation broth was evenly spread on the MHA medium. After the surface of the MHA medium was dry, the antibiotic sensitive paper was placed and incubated at 37°C for 24-48 h. The inhibition diameter around the antibiotic sensitive paper was observed and its sensitivity was determined according to the CLSI standard.
[0027] Hemolysis: The activated lactic acid bacteria were spread on Columbia blood agar and cultured at 37°C for 24 h to observe whether hemolysis occurred. S. aureus IID1617 was used as a positive control strain.
[0028] 1.5 Statistical analysis All experimental data are expressed as mean ± standard deviation. The experiment was repeated in three groups. Student's-test was used for statistical analysis. SPSS 26.0 was used for statistical analysis. MEGA software was used to draw the phylogenetic tree, Chiplot (https: / / www.chiplot.online / ) was used to draw the classification bar graph, and GraphPad Prism9.5.1 software was used to draw the histogram.
[0029] 2 Results and Analysis 2.1 EPS production and biofilm formation ability of kefir-derived lactic acid bacteria Lactic acid bacteria with high EPS production and strong biofilm formation ability can be protected by the external environment. EPS is the "molecular adhesive" in biofilm formation, promoting cell-to-cell adhesion and providing stability for the biofilm structure. At the same time, these characteristics also give lactic acid bacteria different probiotic properties. This lactic acid bacteria participates in kefir fermentation, and its EPS and biofilm play an important role in the stable symbiotic environment of microorganisms in kefir. They can also improve the quality, flavor and nutritional properties of kefir. Therefore, this study is to isolate the kefir Lactobacillus L. kefiri 29. Enterococcus faecium E. faecium 14 EPS production and biofilm formation ability were determined.
[0030] SBF>1.10 indicates strong biofilm formation ability, SBF between 0.70-1.09 indicates medium ability, 0.35-0.69 indicates weak ability, and <0.35 indicates no biofilm formation ability. As shown in Table 1, the two strains have strong biofilm formation ability, among which L. kefiri 29 SBF is 3.48, E. faecium 14 SBF is 1.37. Their EPS yield is relatively high, among which L. Kefiri The EPS yield of 29 was 269.60 μg / mL. E. faecium The EPS production of 14 was 191.44 μg / mL. The results showed that the ability to form biofilms was related to the type of lactic acid bacteria, and the ability to produce EPS was largely due to the inherent characteristics of lactic acid bacteria and had no regularity.
[0031] Table 1 EPS production and biofilm formation ability of kefir-derived lactic acid bacteria No. Strain ID EPS yield / μg / mL SBF 1 29 269.60±3.95 S 2 14 191.44±29.25 S Note: S indicates strong biofilm forming ability.
[0032] 2.2 Characteristic analysis of extracellular vesicles of EPS produced by lactic acid bacteria from kefir By comparing the methods used by previous researchers to study microbial EVs, we found that there are some common problems in the extraction process. For example, failure to perform small molecule filtration will result in microbial residues and reduce the purity of EVs; during ultracentrifugation, too fast a speed or too long a time will damage the membrane structure of EVs, leading to leakage of contents or denaturation of functional proteins; and density gradient centrifugation often results in residual gradient fluid, which, if not completely removed in subsequent steps, will affect the biological activity of EVs. Based on the above effects, this study specifically optimized L. kefiri 29. E. faecium 14. According to the recommendations of the International Society for Extracellular Vesicles, the EVs of two lactic acid bacteria were structurally characterized in terms of morphology, size, and protein content.
[0033] Purified EVs were observed by transmission electron microscopy. Figure 1 , Figure 2 The EVs of the two lactic acid bacteria were structurally intact (the contents were wrapped by a lipid bilayer), which indicated that the method for extracting lactic acid bacteria EVs in this study was feasible. L. kefiri 29EVs are semi-concave spherical structures (see Figure 1 ), E. faecium 14EVs have a typical circular structure (see Figure 2 ). Figure 3 , Figure 4 The particle concentration distribution of EVs with different diameters after EVs dilution, among which the average particle size of L. kefiri 29 is 173nm, with a peak at 158nm. Figure 3 The average particle size of EVs in E. faecium 14 was 171 nm, with a peak value of 163 nm. Figure 4 .
[0034] The detection concentration of L. kefiri 29 was 4.3×10 7 particles / mL. Since the dilution factor before detection was 16000, the actual concentration of L. kefiri 29 was 6.8×10 11 particles / mL. The detection concentration of E. faecium 14 was 5.5×10 7 particles / mL. Since the dilution factor before detection was 200, the actual concentration of L. kefiri 29 was 1.1×10 10 Particles / mL. The EVs concentration of the two strains was high, and the size was within the EVs range standard. Figure 5 The EVs protein content of the two strains. L. Kefiri 29. And E. faecium The protein contents of EVs in 14 samples were 21.71 and 14.81 μg / μL, respectively.
[0035] According to existing literature reports, Lactobacillus kefiri The concentration of KCTC 3611-derived EVs was 7.73×10 7 Particles / mL. Lactobacillus crispatus The concentration of EVs extracted from BCRC 14618 was 10 10 Particles / mL, from Lactobacillus druckerii The concentration of EVs extracted from 7 Particles / mL. Salmonella typhimurium The EVs protein content in CCVCC2226 was 7.3 μg / mL. Bacillus subtilisThe EVs protein content in the strains was 5.1 μg / mL. Therefore, by comparison, we found that the EVs concentration and protein content of the two strains were at a high level. In addition, the strains with different morphologies had differences in EVs concentration and protein content, among which the rod-shaped bacteria ( L. kefiri 29) EVs concentration and EVs protein content are higher than those of cocci ( E. faecium 14).
[0036] It is worth noting that the EVs concentration and protein content of the two strains were positively correlated with their EPS production. This phenomenon is an important sign for lactic acid bacteria to maintain the stability of the microenvironment. High-yield EPS can provide structural support for lactic acid bacteria biofilms, thereby providing a stable platform for information transmission. High EPS production will lead to imbalance in the biosynthesis of peptidoglycan or the insertion of hydrophobic molecules into the outer membrane, resulting in cell disorder, triggering the formation of plasma membrane buds on the cell cavity side and gradually forming multivesicular bodies to release EVs, thereby releasing signal molecules and ensuring mutual communication between cells. EVs contain a variety of proteins, among which adhesion proteins are extremely abundant. These adhesion proteins can bind to EPS and participate in the targeted transport of EVs. Adhesion proteins in EVs and EPS can also provide adhesion substrates, allowing strains to attach to specific surfaces and form biofilm structures. In summary, high-yield EPS helps the release of EVs, thereby increasing the concentration of EVs and ensuring the output of EV cargo. The cargo transported by EVs interacts with EPS. Therefore, high-quality EVs used together with EPS can effectively promote the synergistic effect of microbial communities.
[0037] 2.3 Proteomic analysis of extracellular vesicles of EPS-producing lactic acid bacteria from kefir In order to fully understand the functional information of extracellular vesicles of EPS produced by kefir lactic acid bacteria, label-free quantitative proteomics technology was used to identify L. kefiri 29. E. faecium 14 EVs proteome. Figure 6 It can be seen that a total of 965 proteins were detected in the two strains. L. kefiri 29 There are 951 proteins in EVs. E. faecium There are 116 proteins in 14EVs, with 102 strains of proteins in total. This indicates that the number of proteins in the EVs of the two strains is quite different. L. kefiri 29 EVs are richer in proteins, which is related to the proportion of bacteria in kefir microorganisms. Studies have shown that the dominant lactic acid bacteria in kefir are Lactobacillus kefir, which proves that the physiological state of Lactobacillus kefir is better than that of Enterococcus faecium. By efficiently utilizing nutrients for protein synthesis, more proteins are loaded into EVs. At the same time, this phenomenon is because the cell wall structure of Lactobacillus kefir is more suitable for the formation and release of EVs, so it accumulates more EVs and secretes more proteins.
[0038] 2.3.1 GO analysis In order to fully understand the function, location and biological pathways of proteins in organisms, the top 50 sample proteins in terms of abundance were annotated using gene ontology (GO), such as Figure 7-12 shown. L. kefiri A total of 98 GO terms were obtained for 29 EVs proteins (see Figure 7-9 ), of which there are 43 biological processes (BP), 38 molecular functions (MF), and 17 cell components (CC). E. faecium A total of 109 GO terms were obtained for EVs proteins (see Figure 10-12 ), of which 49 are biological processes, 45 are molecular functions, and 15 are cellular components.
[0039] Depend on Figure 7-12 It can be seen that the EVs of the two lactic acid bacteria have similar functionality in basic metabolic activities, biosynthesis, transmembrane transport, transmission of genetic information, environmental stress and EPS synthesis. These commonalities prove that they play a key role in environmental adaptation, survival and microbial interactions. At the same time, they play an important role in maintaining cell morphology and resisting stress. However, there are also certain differences between them, including L. kefiri GO entries such as cellular ketone metabolism and ribosomal nucleoprotein complex involved in EVs proteins show their specificity in energy metabolism and protein synthesis, thus affecting their growth rate and fermentation capacity. Functions such as stress response and antioxidant response enable them to have defense capabilities in response to environmental changes and maintain stability during the fermentation process. E. faecium 14 EVs proteins participate in proteolysis in the protein degradation process, indicating their activity in nitrogen source utilization and protein decomposition, which helps them to quickly adapt to the environment. The characteristics of defense response to other organisms and response to external stimuli are reflected in E. faecium 14 EVs can actively participate in resisting host immunity and competition with other microorganisms.
[0040] 2.3.2 Subcellular localization like Fig.13 , Fig.14As shown in the figure, the extracellular vesicle proteins of the two lactic acid bacteria were annotated at the subcellular level. The extracellular vesicle proteins of the two lactic acid bacteria are mainly concentrated in the cytoplasm (46-55%), which indicates that the EVs of the two lactic acid bacteria have clear physiological characteristics, especially in metabolic regulation (such as enolase, ATP-dependent protease ATPase subunit Hs1U), cell communication (such as arginine-tRNA ligase, peptide ABC transporter substrate binding protein) and environmental adaptation (such as enolase, elongation factor Tu). It is worth noting that the two lactic acid bacteria EVs proteins co-exist in secretion and lipid anchoring, which have certain functionality. Secretion means that EVs proteins can be actively secreted into the extracellular environment, which means that EVs are not only an extension of bacterial metabolism, but also an important mechanism for bacteria to survive, compete, and interact with microorganisms in complex environments. Lipid anchoring means that substrate-binding proteins are embedded in the membrane of EVs through the lipid part. This anchoring can ensure that the protein remains at a specific position on the membrane, ensuring the efficiency of material transport. In addition, phosphoenolpyruvate catalyzed by enolase in the cytoplasm in the glycolysis pathway is an important precursor for EPS synthesis, while ornithine carbamoyltransferase and arginine-tRNA ligase indirectly support the synthesis of EPS by providing the substrates required for EPS synthesis or promoting the expression of related enzymes.
[0041] At the subcellular level, there are also differences in the extracellular vesicle proteins of the two lactic acid bacteria strains. L. kefiri 29 The ATP synthase β subunit and ATP synthase α subunit of EVs are located as peripheral membrane proteins. They are usually attached to the outside or inside of the cell membrane to participate in the cell signal transduction process, receive external signals and transmit them to the inside of the cell. They may also participate in the interaction with the host or other microorganisms to help regulate bacterial metabolism. ATP synthase β subunit and penicillin binding protein are located in single transmembrane proteins, usually as transporters or signal receptors, transporting small molecules and receiving signals from the environment to help regulate material exchange or regulate the physiological state of bacteria. E. faecium 14 EVs protein alkaline phosphatase is localized in the cell wall and multi-transmembrane proteins, which indicates that it contributes to the maintenance of cell wall structure. By participating in the shaping of the cell wall, it helps to maintain the integrity and functionality of the cell wall under environmental stress. Multi-transmembrane proteins are widely involved in the transmembrane transport of nutrients, ions, metabolic wastes, etc., and are important regulators of cell metabolism and maintaining homeostasis. At the same time, multi-transmembrane proteins have a complex structure and may be involved in more complex signal transduction processes compared to single-transmembrane transport.
[0042] 2.3.3 KEGG pathway analysis like Fig.15 , Fig.16As shown in the figure, the top 50 proteins in terms of abundance in the extracellular vesicles of the two lactic acid bacteria all matched the first level of the five categories: metabolism, genetic information processing, human diseases, environmental information processing, and cellular processes, among which metabolism accounted for the majority. At the second level, the EVs proteins of Lactobacillus kefir matched a total of 45 pathways, and the EVs proteins of Enterococcus faecium 14 matched a total of 42 pathways. L. kefiri 29 EVs, E. faecium There are 26 common pathways in 14 EVs proteins, of which 10 pathways, including metabolic pathways, microbial metabolism in different environments, pyruvate metabolism, carbon metabolism, pentose phosphate pathway, glycolysis / gluconeogenesis, quorum sensing, amino acid biosynthesis, peptidoglycan biosynthesis, and pyruvate, aspartate, and glutamate metabolism, are closely related to the production of exopolysaccharides. They affect the synthesis of exopolysaccharides at different levels, such as providing precursor substances, energy acquisition, structural groups, or regulatory mechanisms. For example, carbon metabolism, glycolysis, and the pentose phosphate pathway provide the carbon source and glycosyl precursors required for the synthesis of exopolysaccharides; pyruvate metabolism provides a variety of energy molecules for polysaccharide synthesis through energy metabolism; amino acid metabolism not only provides structural components such as amino sugars, but also provides essential amino acids for the modification of exopolysaccharides. The peptidoglycan biosynthesis pathway partially shares carbohydrate precursors and intersects with the exopolysaccharide synthesis pathway. It is worth noting that quorum sensing is a mechanism for regulating group behavior by secreting or sensing signal molecules. The proteins involved in quorum sensing are peptide ABC transporter substrate binding proteins, which indicates that L. kefiri 29 EVs, E. faecium 14 EVs can secrete this protein at the same time. On the one hand, it uses this protein to sense and transport signal molecules, transmit them to the inside of the cell, and start the quorum sensing related signal pathway. At the same time, it can also receive external quorum sensing signals to increase the perception density of microbial interactions. On the other hand, through the perception of specific signals by this protein, the expression of genes related to exopolysaccharide synthesis will be activated in the cell to complete the regulation of exopolysaccharide synthesis and help microorganisms form a more stable biofilm structure to promote the survival of the microbial community.
[0043] In addition to the commonly matched pathways, L. kefiri There are 19 unique pathways matched by proteins in EVs (see Fig.15 ), E. faecium 14 There are 16 unique pathways matched by EVs proteins (see Fig.16 ).in, L. kefiri 29 EVs proteins matched to oxidative phosphorylation, TCA cycle, ABC transporter and other pathways, which can regulate the synthesis of extracellular polysaccharides and the formation of biofilms by providing precursor substances or energy; various amino acid metabolic pathways are involved in the modification of extracellular polysaccharides to affect the structure and function of extracellular polysaccharides; vitamin B6 as a coenzyme indirectly affects the synthesis of extracellular polysaccharides through the amino acid metabolic pathway. E. faecium 14 EVs proteins are active in lipid metabolism (glyceride metabolism, fatty acid biosynthesis, fatty acid metabolism) and carbohydrate metabolism (peptidoglycan acid biosynthesis, amino sugar and nucleotide sugar metabolism). These pathways directly affect the synthesis of extracellular polysaccharides. Among them, fatty acid biosynthesis products will participate in the modification or functional regulation of extracellular polysaccharides; fatty acid metabolism will produce intermediates required for extracellular polysaccharide synthesis; amino sugar and nucleotide sugar are key components of extracellular polysaccharide synthesis; peptidoglycan synthesis and extracellular polysaccharide synthesis have an interactive relationship. At the same time, the above pathways fully reflect E. faecium 14 Contribution of EVs proteins in the construction and maintenance of vesicle membrane structure. In drug resistance mechanisms (vancomycin resistance, cholinesterase resistance) and transmembrane transport (ATP-binding cassette transporter) E. faecium 14 EVs proteins play a key role in this.
[0044] In summary, L. kefiri 29 EVs proteins are mainly involved in core energy regulation, amino acid metabolism and other basic metabolic processes, providing energy and precursors for cells, and indirectly promoting the synthesis and secretion of exopolysaccharides. Although they are not directly involved in EPS synthesis, they can regulate the overall metabolic environment of bacterial cells, thereby more efficiently generating exopolysaccharides and forming biofilms. E. faecium 14 The pathways involved in EVs proteins focus more on maintaining the stability of cell structure and the ability to transport substances in response to environmental stress. Some pathways can directly affect the synthesis of EPS. The reason for the large differences in the pathways involved in the EVs proteins of the two lactic acid bacteria is, on the one hand, species specificity, i.e. L. kefiri 29 Physiological roles in fermentation environments and E. faecium 14 Adaptability to survive in complex environments. On the other hand, there are differences in metabolic requirements, i.e. L. kefiri The vesicle protein of 29 provides precursors for cell protein synthesis, indirectly supports the synthesis and secretion of extracellular polysaccharides, and enables the bacteria to form biofilm to adapt to the fermentation environment. E. faecium The vesicle proteins of 14 mainly maintain the mechanical strength of the cells through lipid metabolism and carbohydrate metabolism, and improve the cell's ability to resist pressure. At the same time, the morphological difference of the strains is also one of the key factors that cause the differences in vesicle proteins. L. kefiri 29 has more advantages in movement and nutrient absorption, and improves its environmental adaptability by analyzing EPS and helping cells form biofilms. E. faecium 14. They usually form a tight group structure, which increases the resistance to external pressure by enhancing cell resistance.
[0045] 2.4 Potential probiotic effects of exogenously added EVs on lactic acid bacteria The probiotic properties of lactic acid bacteria are crucial to their application in the food industry. L. Kefiri 29. E. faecium 14) As a control group, we evaluated the effect of exogenously added EVs of lactic acid bacteria (E- L. kefiri 29. E- E. faecium 14) to determine whether EVs mediate the potential probiotic properties of lactic acid bacteria.
[0046] 2.4.1 Adhesion Adhesion ability is an important indicator for evaluating its probiotic properties. Adhesion can directly affect the strain's ability to colonize the intestine. This colonization ability not only allows the strain to firmly adhere to the intestinal mucosa, but also promotes their interaction with the host. At the same time, adhesion ability is also related to the stability of food processing and storage, which can most directly affect product quality and probiotic efficacy. Self-aggregation and hydrophobicity are important indicators of lactic acid bacteria's adhesion ability. Fig.17 As shown in the figure, both strains in the control group showed strong self-aggregation, and in the experimental group, the self-aggregation of the strains was significantly improved after exogenous addition of EVs. After 1 hour of culture, the self-aggregation of the strains was higher than that of the control group (83.22-86.54%), and its self-aggregation ability gradually increased with the increase of culture time. Fig.18 As shown, L. kefiri 29. E. faecium The hydrophobicity of 14 strains to xylene was 46.93% and 64.33%, respectively, which indicated that the two strains had strong hydrophobicity. With the addition of exogenous EVs, their hydrophobicity was significantly improved. L. kefiri 29 The hydrophobicity is significantly improved ( P<0.001 ).
[0047] The effect of exogenously added EVs on the high adhesion of lactic acid bacteria is closely related to their sources. L. kefiri 29. E. faecium 14 are all derived from kefir strains with high EPS production, and there is a certain correlation between their high EPS production and the adhesion of lactic acid bacteria. This correlation is enhanced by exogenous supplementation. In the proteomic analysis of EVs of two strains, it was found that a variety of proteins indirectly or directly affect the synthesis of EPS through metabolic pathways. This in turn affects the cell adhesion ability. These findings show that EVs, as regulatory molecules, not only transmit signals between cells, but also improve the adhesion of lactic acid bacteria through close interaction with EPS synthesis.
[0048] 2.4.2 Acid and bile resistance The pH value of gastric acid in human gastric juice is usually 3.0, and the pH value of bile salts in the small intestine is 0.3%. The time it takes for food to pass through the stomach and small intestine is usually within 4 hours. In this study, a gastric acid environment with a pH of 3 and a small intestinal environment containing 0.3% bile salts were used to treat lactic acid bacteria for 0 and 3 hours, respectively, to simulate the colonization of strains in human gastrointestinal fluid. In Table 2, the S category is the result of strain acid resistance, and the D category is the result of strain bile salt resistance. It can be seen from the S category in Table 2 that the number of live bacteria of lactic acid bacteria with exogenously added EVs showed a slight downward trend after 3 hours in an acidic environment. It can be seen from the D category in Table 2 that the E- L. kefiri 29 After 3 hours in the bile salt environment, the number of viable bacteria showed a downward trend, while E- E. faecium 14 After 3 hours in the bile salt environment, the number of viable bacteria showed an upward trend. From the results of the control group, we can see that E. faecium 14 Enhances its ability to grow and proliferate by inducing adaptability and stimulating stress responses in extreme environments, and its survival ability is stronger after exogenous addition of EVs. This result is consistent with the functionality of the EVs protein of this strain found above, further demonstrating the role of EVs in the biological self-protection mechanism. In summary, the survival rates of different lactic acid bacteria in gastrointestinal fluid vary to a certain extent, but all exceed 90%. After exogenous addition of EVs of the corresponding strains, the acid and bile resistance of the strains are significantly improved, which indicates that the addition of EVs can enable the corresponding lactic acid bacteria to have a stronger tolerance to the gastrointestinal environment, thereby more effectively exerting their functional characteristics.
[0049] Table 2 Acid and bile resistance of lactic acid bacteria with exogenously added EVs
[0050] Note: S is the result of strain acid resistance, D is the result of strain bile resistance.
[0051] 2.4.3 Antibacterial properties The antibacterial activity of lactic acid bacteria is an important factor in preventing infection and invasion by pathogens. This study investigated whether the metabolites produced by lactic acid bacteria have antibacterial activity and whether the antibacterial activity of strains exogenously added with EVs is enhanced. E. coli NBRC3301, S. aureus II D1617 and S. typhimurium NBRC12529 was used for antibacterial test.
[0052] As shown in Table 3, the relative inhibition rates of the experimental group against the three pathogens were all greater than those of the control group. L. kefiri The relative inhibition rates of 29 against three pathogenic bacteria were 51.46 - 54.21%, E- E. faecium The relative inhibition rates of E-14 against three pathogens were 52.08 - 54.91%, which indicated that L. kefiri 29. E- E. faecium 14 had antibacterial effects on the three pathogens, and they E. coli NBRC3301 had the highest inhibitory activity (54.21%, 54.91%). The significance analysis of different pathogens of the same lactic acid bacteria showed that (relative inhibition rate with lowercase letters above), E- L. kefiri 29 fermentation broth had significant antibacterial activity against the three pathogens ( p<0.05 ). The significance analysis of different lactic acid bacteria against the same pathogen showed that (the relative inhibition rate is superscripted with capital letters) S. aureus Under the influence of ⅡD1617, there was no difference in the antibacterial activity of the fermentation broth of the two lactic acid bacteria ( p>0.05 ), while under the influence of the other two pathogens, there was a significant difference in the antibacterial activity of lactic acid bacteria in the experimental group ( p< 0.05 ). The results show that E- L. kefiri The fermentation broth of 29 had antibacterial activity against a variety of pathogens, indicating that the bacterium had a broad-spectrum antibacterial potential. E. faecium 14 The fermentation broth has selective antibacterial ability against pathogens. At the same time, the two experimental groups of lactic acid bacteria have great differences under the influence of different pathogens, which indicates that there are obvious differences in the types and characteristics of their antibacterial metabolites. This phenomenon further supports the important role of EVs in antibacterial effects. EVs can serve as a delivery carrier to transport metabolites rich in highly effective antibacterial substances to pathogens, thereby enhancing the antagonistic effect on pathogens. At the same time, EVs can effectively interfere with the cell membrane or metabolic activity of pathogens, thereby enhancing the original antibacterial effect of lactic acid bacteria.
[0053] Table 3 Antibacterial ability of lactic acid bacteria fermentation broth with exogenously added EVs
[0054] Note: Lowercase letters indicate the significance of the same lactic acid bacteria in different pathogens. Uppercase letters indicate the significance of the same pathogen in different lactic acid bacteria.
[0055] 2.4.4 Safety evaluation In order to evaluate the safety of the two strains of lactic acid bacteria exogenously added to EVs, we measured their drug resistance and hemolytic ability. Table 4 shows the drug sensitivity results of the experimental group and the control group to 9 antibiotics. The results showed that both strains were resistant to ciprofloxacin and norfloxacin in the quinolone class of drugs. E. faecium The drug resistance of 14 was significantly higher than L. kefir 29. Enterococcus faecium was initially considered a commensal bacterium that was harmless to humans, but as it evolved over a long period of time, virulence genes emerged, making it more resistant than other strains. L. kefiri29 were sensitive to five types of antibiotics: cephalosporins (CZO), β-lactams (PEN, AMP), macrolides (E), aminoglycosides (G, AMI) and phenols (CHL). L. kefiri 29 are sensitive to multiple antibiotics, E. faecium 14 showed a certain degree of drug resistance. In fact, antibiotic resistance itself is not a safety issue. As long as there is no risk of resistance gene transfer, it will not pose a threat to human health. Therefore, under the premise of strict control or reasonable application, E. faecium The risk of drug resistance of 14 is controllable, and its probiotic effect can still be fully exerted. In addition, the exogenous addition of EVs has no effect on the drug resistance of the strain. This phenomenon shows that the drug resistance of the strain is a relatively independent biological characteristic that depends more on intrinsic genetic factors rather than external molecular regulation. Therefore, when using exogenous EVs to enhance the function of lactic acid bacteria, it will not have an adverse effect on its own drug resistance.
[0056] Hemolytic bacteria are seriously harmful to the human body, and hemolysis is an important part of in vitro evaluation of the safety of lactic acid bacteria. S. aureus IID1617 was used as a control. Figure 19 As shown, S. aureus ⅡD1617 showed β-hemolysis. A clear and completely transparent hemolytic ring of 2-4 mm was observed around the strain. However, no hemolysis was observed in the two lactic acid bacteria to which EVs were exogenously added. The results showed that the two lactic acid bacteria to which EVs were exogenously added did not show the ability to attack red blood cells under experimental conditions, so the addition of EVs was further confirmed in terms of strain safety.
[0057] Table 4 Drug resistance of lactic acid bacteria with exogenously added EVs
[0058] Note: S: sensitive, I: intermediate, R: resistant. CZO: cefazolin (30 μg); PEN: penicillin (10 μg); AMP: ampicillin (10 μg); E: erythromycin (15 μg); G: gentamicin (10 μg); AMI: amikacin (30 μg); CHL: chloramphenicol (30 μg); CIP: ciprofloxacin (5 μg); NFX: norfloxacin (10 μg).
[0059] This study found that kefir-derived lactic acid bacteria L. kefiri 29 and E. faecium The EVs concentration of 14 is proportional to its EPS production, which indicates that high EPS production induces the formation of EVs, and the cargo proteins of EVs are directly involved in the formation and regulation of EPS. L. kefiri 29 EVs are more sensitive to the fermentation environment and rely on protein signals to perceive environmental changes. These proteins are mainly involved in basic metabolism related to fermentation to ensure that the strain can respond quickly to environmental changes. E. faecium 14 EVs showed a relatively complex signal transduction network, and its proteins mainly regulated lipid metabolism and carbohydrate metabolism, maintaining the mechanical strength of cells and improving their stress resistance, thereby ensuring the survival of bacteria. Both lactic acid bacteria EVs can mediate EPS synthesis, mainly through the following three pathways: providing precursor substances, providing energy, and indirectly promoting the activity of synthases. L. kefiri 29 EVs proteins performed particularly well. In terms of potential probiotics, the analysis results of the probiotic characteristics of two lactic acid bacteria strains with exogenous addition of EVs showed that the addition of EVs significantly improved the strains' adhesion, acid and bile resistance, antibacterial properties, and safety, especially adhesion. This result intuitively verified the functional role of pathways related to EPS synthesis in EVs proteomics and the potential probiotic value of EVs on the functional characteristics of strains.
[0060] Highly adhesive lactic acid bacteria have significant advantages in fermented milk. First, it enhances the colonization ability of lactic acid bacteria in the intestine. Highly adhesive lactic acid bacteria can firmly adhere to intestinal epithelial cells and form biofilms, thereby ensuring its stability in the intestinal environment and exerting its probiotic function. At the same time, lactic acid bacteria colonizing the intestine can not only inhibit the growth of harmful microorganisms and promote the effective absorption of nutrients, but also activate the intestinal immune system, thereby protecting intestinal health and preventing the occurrence of intestinal-related diseases. Second, it improves product quality. Highly adhesive lactic acid bacteria can effectively aggregate to form cell clumps, which interact with fermented milk components (such as whey protein, casein and lipids) to build a more stable microstructure. At the same time, the high-yield EPS in lactic acid bacteria plays a key role in the system. It acts as a "bridge" to connect protein molecules and other components, which makes the three-dimensional network structure of fermented milk more compact and greatly improves the degree of polymerization of the system. In addition, EPS significantly enhances the rheological properties of the product through cross-linking with fermented milk components, causing it to exhibit shear thinning under the action of shear force. At the same time, during the fermentation and storage of fermented milk, high-adhesion strains can interact well with other ingredients in dairy products (such as protein and fat), improve flavor and enhance product quality. Finally, ensure product stability during storage. The efficient aggregation ability of high-adhesion strains and the network structure co-constructed by their EPS and milk components can reduce the relative movement of solid and liquid components in fermented milk, thereby maintaining the physical stability of the product. Aggregated cell clumps can wrap various components in fermented milk together to form a stable suspension system, thereby effectively inhibiting the precipitation of the product. Rheological properties can ensure that the product has the ability to resist shear force and gravity during storage, thereby reducing the risk of product stratification. Therefore, high-yield EPS lactic acid bacteria with strong adhesion can be used as an important resource for the development of high-quality fermented milk products, so as to exert their probiotic effects and enhance the nutritional value of the product.
[0061] Finally, it should be noted that the above content is only used to illustrate the technical solution of the present invention, rather than to limit the scope of protection of the present invention. Simple modifications or equivalent substitutions of the technical solution of the present invention by ordinary technicians in this field do not deviate from the essence and scope of the technical solution of the present invention.
Claims
1. A method for extracting extracellular vesicles of kefir-derived lactic acid bacteria, characterized in that The steps include: 1) The fermentation culture of kefir-derived lactic acid bacteria was centrifuged at 4°C and 10,000 × g for 30 min to remove cell debris and collect the supernatant; 2) Use a 0.45 μm filter membrane to filter out floating impurities in the supernatant; 3) The supernatant was concentrated 25 times by ultrafiltration through a 100 KD ultrafiltration tube, and the concentrate was transferred to a centrifuge tube; 4) Blow 100 uL PBS buffer into the 100 KD ultrafiltration tube described in step 3) and collect the leaked liquid; 5) The concentrated solution in step 3) is mixed with the leaked solution in step 4) to obtain a final concentrated solution, and the final concentrated solution is filtered using a 0.22 um filter membrane to obtain a crude EVs extract; 6) The crude EVs extract was purified by ultra-high-speed centrifugation at 4°C and 120,000×g for 90 min. The EVs precipitate was resuspended in 100 uL PBS buffer precooled to 4°C and stored at -80°C.
2. The use of the extracellular vesicles extracted by the extraction method according to claim 1 in improving the potential beneficial activity of lactic acid bacteria, characterized in that: The isolated kefir-derived lactic acid bacteria extracellular vesicles were diluted to a concentration of 1 μg / mL, exogenously added to the lactic acid bacteria strain at a 10% v / v inoculation rate, mixed, and cultured at 37°C for 24 h.
3. The use according to claim 2, characterized in that: The probiotics are the adhesion, acid and bile resistance and antibacterial properties of the lactic acid bacteria to which the kefir-derived lactic acid bacteria extracellular vesicles are exogenously added.
Citation Information
Patent Citations
Preparation method and application of lactobacillus amyloliquefaciens extracellular vesicles
CN116606766A
Method for ameliorating or treating a bowel disease
US10632161B1
